EIKN

Conviction 59HealthcareScan · Mon, Aug 10, 2026

EIKN$9.74+4.79%

ResistanceSupportVol 14

Vol MA14 434.04K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Eikon Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.eikontx.com ↗

Price9.74

Change+4.79%

Gap+1.61%

Rel volume7.38×

Avg volume376.84K

Avg $ vol3.61M

SMA 209.56

SMA 509.98

SMA 200—

Price vs 50-2.43%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 11.60

RSI (14)50

MACD hist0.03

MACD crossbull · 0d

Stoch %K / %D69 / 46

ADX (14)12

+DI / −DI14 / 14

RSI divergence—

MACD divergence—

ATR %+7.81%

ADR %7.17%

52w high16.26

52w low8.36

From 52w high-40.13%

Above 52w low+16.45%

New 52w highNo

SqueezeOn · 5d

Bollinger width13.80%

%B0.63

Donchian pos54.86%

Donchian high10.57

Donchian low8.72

AVWAP (52w high)11.70

vs AVWAP high-16.80%

AVWAP (52w low)10.45

vs AVWAP low-6.83%

OBV trendUp

Chaikin MF (20)0.08

Today vs 20d7.38×

Avg vol (14d)434.04K

Avg vol (20d)376.84K

Avg $ vol (20d)3.61M

Market cap527.04M

RS 3m (vs SPY)-4.39%

RS 6m (vs SPY)-52.18%

RS line new highNo

Trend template—

Technical rank21.1

1 week+6.39%

1 month-7.99%

3 months-2.26%

6 months-32.86%

1 year—

YTD-35.10%

P/E—

P/B0.96

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current11.75

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value365.89M

Revenue—

Net income-82.96M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out54.14M

Employees384

ListedThu, Feb 5, 2026

Free float26.6M

Float %49.1%

Short interest4.63M

Days to cover11.5d

Short volume33.6%

Squeeze score75 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction59 / 100

Pattern quality—

Tech rank21.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.95

Support8.82

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EIKN

All disclosures →

No recent disclosed trades by Congress in EIKN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EIKN

No recent insider (Form 4) filings in EIKN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in EIKN · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.